Table 1.
Patient Characteristics
| No. of patients | |
|---|---|
| Median age (range) | 73 years (57–91) |
| Gender | |
| Male | 15 |
| Female | 10 |
| PS (ECOG) | |
| 0–1 | 16 |
| ≥2 | 9 |
| Histological type | |
| TCC | 22 |
| Adenocarcinoma | 1 |
| Squamous | 1 |
| NEC | 1 |
| Primary site | |
| Bladder | 21 |
| Ureter | 3 |
| Allantoic duct | 1 |
| UICC T classifications | |
| T2 | 10 |
| T3 | 8 |
| T4 | 7 |
| Node classifications | |
| Negative | 17 |
| Positive | 8 |
| Distant metastases | |
| Yes | 3 |
| No | 22 |
| Hemoglobin (g/dL) | |
| <9.3 | 11 |
| ≥9.3 | 13 |
| Unknown | 1 |
| Creatinine (mg/dL) | |
| <0.95 | 11 |
| ≥0.95 | 13 |
| Unknown | 1 |
| Irradiation dose | |
| 20 Gy/5 fr. | 7 |
| 30 Gy/10 fr. | 17 |
| 40 Gy/20 fr. | 1 |
| History of pretreatment blood transfusion | |
| Yes | 9 |
| No | 16 |
| History of chemotherapy before irradiation | |
| Yes | 14 |
| No | 11 |
ECOG, Eastern Cooperative Oncology Group; fr, fractions; NEC, neuroendocrine carcinoma; PS, performance status; TCC, transitional cell carcinoma; UICC, Union for International Cancer Control.